Metraipolis › archive › dc_374ffa0f47ee

Endogenous living adjuvants for cancer vaccination: Concepts, mechanisms, and design principles — Europe PMC PMID:42146112

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42146112
DOI
10.1016/j.mtbio.2026.103020
License (as archived)
solo-consultazione
Archived
2026-11-04T21:35:44.997Z
SHA-256 of the archived text
adccfba001e2a0d42628c81054d472467ab47e8ba10da2cc61483b475f7102ef
Stable URL of this page
https://metraipolis.com/documento/dc_374ffa0f47ee

How to cite

Endogenous living adjuvants for cancer vaccination: Concepts, mechanisms, and design principles — Europe PMC PMID:42146112 — Europe PMC (en), https://europepmc.org/article/MED/42146112 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_374ffa0f47ee (Metraipolis archive dc_374ffa0f47ee, sha256 adccfba001e2a0d42628c81054d472467ab47e8ba10da2cc61483b475f7102ef)
BibTeX
@misc{dc374ffa0f47ee,
  title = {Endogenous living adjuvants for cancer vaccination: Concepts, mechanisms, and design principles — Europe PMC PMID:42146112},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42146112},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_374ffa0f47ee; sha256 adccfba001e2a0d42628c81054d472467ab47e8ba10da2cc61483b475f7102ef},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42146112. Agents can read the archived copy with the MCP tool read_document.